Skip to main content
OpenTrials
Completed

NCT Number: NCT03658044

Social Media on Prescription for Colorectal Cancer Patients

The overall aim with this study is to get a deeper understanding of the potential benefits with a health platform for patients diagnosed with colorectal cancer.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Colorectal Cancer Colonic Diseases Colorectal Neoplasms Digestive System Diseases Digestive System Neoplasms Gastrointestinal Diseases Gastrointestinal Neoplasms Intestinal Diseases Intestinal Neoplasms Neoplasms Neoplasms by Site Rectal Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Dept. of Surgery, Sahlgrenska University Hospital/Ostra

Gothenburg, SE 416 85, Sweden

About this study

This is a prospective randomized parallel group design. Consecutive patients will be recruited from participating hospitals and randomized to either "prescribed participation" or just receiving information about the platform but with no prescription.

All patients are also receiving standard care. After treatment all patients will receive information about the platform and the aim with the platform. A short demonstration of the platform will also be provided. The platform will contain general information on "Life after cancer treatment". It will be a forum to discuss with fellow-patients, both experienced and newly treated and it is also possible to address questions to health professionals. After the demonstration an information about the study will be given and patients will be asked to participate. If accepted a consent form will be presented and signed by the patients. All patients will be given an alias - a username, to be used at the platform which gives the patients confidentiality. However, as this is a research project they will be informed that their clinical data will be extracted from their patient charts. The alias will in a separate file be connected with their personal identification number. The patients randomized to intervention (prescribed participation) will be offered to contact a research nurse or researcher if they have any practical questions regarding the use of the platform. All patients will be asked to answer a questionnaire at baseline, 3, 6 and 12 months after surgery. Patients will be answering the questionnaires electronically on the platform or in a paper version sent by ordinary mail.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Colorectal cancer diagnosis within 1 year
  • Must be able to speak and read the Swedish language
  • Must be able to use the health platform

Exclusion criteria

-Inability to speak and read the Swedish language

Treatment and study plan

Participation in the internet forum

Other

Active participation in the forum with encouragement to participate on a weekly basis

Placebo

Other

No intervention performed. Patients are offered to read the open pages on the website

Primary outcomes

  1. Self empowerment measured by Cancer Behavior Inventory (CBI) scale

    Time frame: 12 months

    A 12-item measure of self-efficacy for coping with cancer that measures self empowerment and coping. Each question is answered on a 9 point Likert scale. The higher the score the more confident and self empowered

Secondary outcomes

  1. Self empowerment measured by Cancer Behavior Inventory (CBI) scale

    Time frame: 3 months

    A 12-item measure of self-efficacy for coping with cancer that measures self empowerment and coping. Each question is answered on a 9 point Likert scale. The higher the score the more confident and self empowered

  2. Compliance to treatment

    Time frame: 12 months

    How frequent is the forum used? Will be tested using newly developed questions in a questionnaire. There will be a scale from 1-5

  3. Quality of life using a Likert scale question tested in several other studies

    Time frame: 12 months

    Using an assessment on a Likert scale 0-7 "How would you rate your QoL?"

  4. Usability of a health care platform

    Time frame: 12 months

    Is the platform easy to use? Will be tested using newly developed questions with 4-6 answering options.

  5. Generated Knowledge in Online Discussions

    Time frame: 3 years

    A qualitative analysis of the online discussions on the forum

Sponsors and collaborators

Lead sponsor

Sahlgrenska University Hospital

Other

Collaborators

  • Högskolan Väst

Registry information

Official study title

SMOP - Social Media on Prescription, a Randomised Controlled Trial

Acronym: SMOP

Important dates

Study start
2018
Primary completion
2020
Study completion
2021
First posted
Sep 5, 2018
Registry last updated
Nov 7, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.